An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
Opass Putcharoen,1–3 Stephen J Kerr,4 Kiat Ruxrungtham2,4,5 1Division of Infectious Diseases, Department of Medicine, Chulalongkorn University, 2Faculty of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Chulalongkorn University, 3Center of Excellence for Infectious...
Enregistré dans:
Auteurs principaux: | Putcharoen O, Kerr SJ, Ruxrungtham K |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ec33a39843224dbd9b05ab35b8bbfda7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maraviroc
par: Eva Poveda, et autres
Publié: (2010) -
Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir
par: Wainberg MA
Publié: (2013) -
Dolutegravir/rilpivirine for the treatment of HIV-1 infection
par: Dowers E, et autres
Publié: (2018) -
Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
par: Nanzigu S, et autres
Publié: (2013) -
New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir
par: Patel N, et autres
Publié: (2012)